Claypoole Robert E 4

4 · Bioventus Inc. · Filed Mar 17, 2026

AI-generated summary of this filing

Updated Mar 17, 2026

Bioventus (BVS) CEO Robert Claypoole Exercises/Converts RSUs; Shares Withheld for Taxes

What Happened

Robert E. Claypoole, President, CEO and Director of Bioventus (BVS), converted/exercised 33,500 derivative awards into Class A common shares on 2026-03-13. To satisfy tax withholding obligations, 14,553 of those shares were surrendered at an effective price of $8.62, yielding $125,447. The filing also records multiple prior and contemporaneous awards (RSUs/options) granted in 2025 and 2026.

Key Details

Primary transaction dates: 2026-03-13 (conversion/exercise and tax withholding) and prior grant dates 2025-03-14 and 2026-03-13.
Conversion/exercise: 33,500 derivative shares converted into common stock on 2026-03-13 (reported $0.00 per share, consistent with RSU conversion).
Tax withholding (code F): 14,553 shares surrendered at $8.62 per share to satisfy withholding = $125,447.
Awards reported (grants/derivatives): 134,000 and 153,000 (granted 2025-03-14), and 278,000 and 309,000 (granted 2026-03-13) — aggregate 874,000 RSUs/options shown in the filing.
Footnotes: F1—each RSU equals a contingent right to one share; F2/F3—RSUs/options vest in four equal annual installments beginning March 15, 2025 (for the 2025 grants) and March 15, 2026 (for the 2026 grants), subject to continued service.
Shares owned after the transactions are not specified in the provided data.
Filing date: 2026-03-17. The filing lists transactions on 2025-03-14 and 2026-03-13; no late-filing flag was provided in the materials you supplied.

Context

This appears to be a routine compensation/vesting event (conversion of RSUs/options) rather than an open-market buy or sell. The surrender of shares was for tax withholding (common in net settlement of RSUs) rather than a market sale for investment purposes.
For retail investors: such conversion/withholding events reflect compensation vesting and do not necessarily indicate the insider is bullish or bearish on the stock.

Form 4

Period: 2025-03-14

DirectorPresident and CEO

Transactions

Exercise/Conversion
Class A Common Stock
2026-03-13+33,500→ 150,497 total
Tax Payment
Class A Common Stock
2026-03-13$8.62/sh−14,553$125,447→ 135,944 total
Award
Restricted Stock Units
[F1][F2]
2025-03-14+134,000→ 134,000 total
→ Class A Common Stock (134,000 underlying)
Award
Stock Option (Right to Buy)
[F2]
2025-03-14+153,000→ 153,000 total
Exercise: $9.61Exp: 2035-03-14→ Class A Common Stock (153,000 underlying)
Award
Restricted Stock Units
[F1][F3]
2026-03-13+278,000→ 278,000 total
→ Class A Common Stock (278,000 underlying)
Award
Stock Option (Right to Buy)
[F3]
2026-03-13+309,000→ 309,000 total
Exercise: $8.62Exp: 2036-03-13→ Class A Common Stock (309,000 underlying)
Exercise/Conversion
Restricted Stock Units
[F1][F2]
2026-03-13−33,500→ 100,500 total
→ Class A Common Stock (33,500 underlying)

Footnotes (3)

[F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
[F2]The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date.
[F3]The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date.

Signature

/s/ Anthony D'Adamio, Attorney-in-Fact|2026-03-17

1 file